Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

abrdn Life Sciences Investors (NY: HQL )

14.29 +0.03 (+0.21%)
Official Closing Price Updated: 7:00 PM EDT, Jul 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 88,572
Open 14.30
Bid (Size) 14.04 (1)
Ask (Size) 15.00 (1)
Prev. Close 14.26
Today's Range 14.24 - 14.38
52wk Range 11.34 - 14.38
Shares Outstanding N/A
Dividend Yield 8.96%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
Via ACCESSWIRE
abrdn Life Sciences Investors (HQL) Announces Results of Annual Meeting of Shareholders
Via ACCESSWIRE

Performance

YTD
+4.08%
+4.08%
1 Month
+6.40%
+6.40%
3 Month
+8.42%
+8.42%
6 Month
+4.08%
+4.08%
1 Year
+6.32%
+6.32%

More News

Read More
Around $1.5M Bet On Abrdn Life Sciences Investors? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
Via ACCESSWIRE
abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update
Via ACCESSWIRE
abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce a 25% Increase in Distribution Rates and abrdn Healthcare Opportunities Fund (THQ) Announces a 60% Increase in Distribution Rate
Via ACCESSWIRE
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
Via ACCESSWIRE
Tekla Capital Management LLC Announces Closing of Transaction With abrdn
From Tekla Capital Management LLC
Via Business Wire
Tekla Funds Approve New Investment Advisory Agreements With abrdn Inc.
From Tekla Capital Management LLC
Via Business Wire
abrdn Announces Its Appointment to Four U.S. Specialist Healthcare Closed-End Funds, New Board of Trustees to the Funds and Fund Name Changes
Via ACCESSWIRE
Tekla Funds Implore Shareholders of THQ and THW to Vote Immediately to Realize Potential Cost Savings for the Funds
From Tekla Capital Management LLC
Via Business Wire
Tekla Funds Urge Shareholders to Vote Immediately to Guarantee Reduced Fund Expenses
From Tekla Capital Management LLC
Via Business Wire
Tekla Life Sciences Investors Paid Distribution
From Tekla Life Sciences Investors
Via Business Wire
Tekla Funds Announce Adjournment of Special Meetings and Implore Shareholders to Vote Their Shares Immediately
From Tekla Capital Management LLC
Via Business Wire
Tekla Funds Announce Second Adjournment of Special Meetings and Urge Shareholder Participation to Limit the Need for Further Solicitation Efforts
From Tekla Capital Management LLC
Via Business Wire
Wednesday Is Your Last Chance To Buy Tekla Life Sciences Invts Before The Dividend Payout
Via Benzinga
Tekla Life Sciences Investors Declares Distribution
From Tekla Life Sciences Investors
Via Business Wire
Tekla Funds Announce Adjournment of Special Meetings
From Tekla Capital Management LLC
Via Business Wire
Tekla Life Sciences Investors Paid Distribution
From Tekla Life Sciences Investors
Via Business Wire
abrdn to Acquire US Specialist Healthcare Closed-End Funds with $3 Billion AUM
Via ACCESSWIRE
Tekla Capital Management LLC Announces Proposed Transaction
From Tekla Capital Management LLC
Via Business Wire
Tekla Life Sciences Investors Declares Distribution
From Tekla Life Sciences Investors
Via Business Wire
Tekla Life Sciences Investors Paid Distribution
From Tekla Life Sciences Investors
Via Business Wire
Tekla Healthcare Opportunities Fund Paid Distribution
From Tekla Healthcare Opportunities Fund
Via Business Wire
Tekla Healthcare Investors Paid Distribution
From Tekla Healthcare Investors
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.